CIK 0001609809
- Non-accelerated filer
- Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 274326290
- Phone
- +1 617-945-9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- 4 Planned sale Henn Matthew R. sold 927 shares at $0.54 ($501)
- 4 Planned sale von Moltke Lisa sold 4,334 shares at $0.69 ($2,991)
- 4 Planned sale Henn Matthew R. sold 3,984 shares at $0.69 ($2,749)
- 4 Planned sale Chief Legal Officer and EVP sold 4,259 shares at $0.69 ($2,939)
- 4 Planned sale CEO and President sold 8,748 shares at $0.69 ($6,037)
- 4 Planned sale Young Teresa L. sold 2,983 shares at $0.69 ($2,059)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Legal Officer and EVP sold 873 shares at $0.84 ($733)
- 4 Planned sale von Moltke Lisa sold 973 shares at $0.84 ($817)
- 4 Planned sale Henn Matthew R. sold 923 shares at $0.84 ($775)
- 4 Planned sale CEO and President sold 2,518 shares at $0.84 ($2,115)
- 4 Planned sale Young Teresa L. sold 728 shares at $0.84 ($612)
- 4 Planned sale Ege David S. sold 1,128 shares at $0.84 ($948)
- 4 Planned sale Young Teresa L. sold 24,480 shares at $1.08 ($26,534)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale von Moltke Lisa sold 939 shares at $0.94 ($883)
- 4 Planned sale CEO and President sold 2,435 shares at $0.94 ($2,289)
- 4 Planned sale Young Teresa L. sold 703 shares at $0.94 ($661)
Page 5 of 19 · 380 filings